Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardiac Pathways CE-marks diagnostic catheters:

This article was originally published in Clinica

Executive Summary

Cardiac Pathways has CE-marked its Trio/Ensemble diagnostic catheters for sale in south Europe. The devices are used for the diagnostic mapping of supraventricular tachycardia (SVT), a rapid heart rhythm that originates above the ventricles in the heart. Doctors using the Trio/Ensemble system can place three catheters inside a patient through a single incision, instead of three separate ones, and assess the electrical conduction between the atria and ventricle. The SVT is then treated using radiofrequency catheter ablation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel